Siddharta, AnindyaAnindyaSiddhartaPfänder, StephanieStephaniePfänderVielle, Nathalie JaneNathalie JaneVielleDijkman, RonaldRonaldDijkmanFriesland, MartinaMartinaFrieslandBecker, BrittaBrittaBeckerYang, JaewonJaewonYangEngelmann, MichaelMichaelEngelmannTodt, DanielDanielTodtWindisch, Marc PMarc PWindischBrill, Florian HFlorian HBrillSteinmann, JoergJoergSteinmannSteinmann, JochenJochenSteinmannBecker, StephanStephanBeckerAlves, MarcoMarcoAlvesPietschmann, ThomasThomasPietschmannEickmann, MarkusMarkusEickmannThiel, Volker EarlVolker EarlThielSteinmann, EikeEikeSteinmann2025-01-082025-01-082017-03-15https://boris-portal.unibe.ch/handle/20.500.12422/199771The World Health Organization (WHO) published 2 alcohol-based formulations to be used in healthcare settings and for outbreak-associated infections, but inactivation efficacies of these products have not been determined against (re-)emerging viruses. In this study, we evaluated the virucidal activity of these WHO products in a comparative analysis. Zika virus (ZIKV), Ebola virus (EBOV), severe acute respiratory syndrome coronavirus (SARS-CoV), and Middle East respiratory syndrome coronavirus (MERS-CoV) as (re-)emerging viral pathogens and other enveloped viruses could be efficiently inactivated by both WHO formulations, implicating their use in healthcare systems and viral outbreak situations.enEbola virus SARS WHO Zika virus MERS600 - Technology::630 - Agriculture500 - Science::570 - Life sciences; biology600 - Technology::610 - Medicine & healtharticle10.7892/boris.1120642845383910.1093/infdis/jix046